ArticleJournal of robotic surgery2025
Mastering the robot-assisted pyeloplasty learning curve: analysis of operative efficiency, safety, and functional outcomes.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Global research trends in robot-assisted pyeloplasty: a bibliometric and visualization analysis.Journal of robotic surgery · 2026Review
- Global research trends and thematic evolution in robot-assisted pyeloplasty for ureteropelvic junction obstruction: a bibliometric and visualization study.Journal of robotic surgery · 2026Article
- Critique of "Mastering the robot-assisted pyeloplasty learning curve".Journal of robotic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robot-assisted pyeloplasty (RAPY) for ureteropelvic junction obstruction (UPJO) is a technically challenging procedure. This study evaluates the learning curve by analyzing operative time, complications, and renal function recovery across sequential cases. A retrospective study of sixty consecutive patients who underwent RAPY between 2019 and 2024, performed by a single surgeon in a specialized robotic department, was performed. Cases were divided into three phases: early (first 20), middle (21-40), and late (41-60). Outcomes included operative time, complications (as classified by the Clavien-Dindo system), length of hospital stay, and improvement in glomerular filtration rate GFR. Mean age was 56 years, 57% of UPJO was on the left side. 55% of patients were males, 90% presented with symptoms, and the mean lateral distribution of the affected kidneys in renal scintigraphy statistical analysis was 32%. All preoperative parameters showed no significant differences among the study groups. The mean console time was 91 min. The mean hospital stay was 4.8 days, and the mean bladder catheter days were 4.2 days. Operative time decreased significantly from the early to the late phases (118 ± 28 vs. 65 ± 18 min, p < 0.001). The overall complication rate was 16%, minor complications 11%, and major complications 5%. Major complications (Clavien ≥ III) decreased from 25 to 5% (p =0.02) from the early to the late phase. Five patients were readmitted within 90 days after surgery. GFR improvement was consistent across all phases (+ 14.2 mL/min, p =0.25). The RAPY learning curve plateaus at 40 cases, with optimized efficiency and safety and significant improvements in both efficiency and safety until then.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.